Loading data
ACXPNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Research and development expense | 1.83 m USD | 5.4 m USD | 6.04 m USD | 4.75 m USD | 2.03 m USD |
| Selling, general and administrative expense | — | — | — | — | 208.27 k USD |
| Operating profit | -8.09 m USD | -14.12 m USD | — | — | — |
| Net income (reported basis) | -7.97 m USD | -14.1 m USD | -14.58 m USD | -12.09 m USD | -12.75 m USD |
| Basic earnings per share | -5.32 USD/share | -17.45 USD/share | -1.15 USD/share | -1.12 USD/share | -1.49 USD/share |
| Diluted earnings per share | -5.32 USD/share | -17.45 USD/share | -1.15 USD/share | -1.12 USD/share | -1.49 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.